54
Participants
Start Date
July 1, 2017
Primary Completion Date
June 30, 2019
Study Completion Date
December 30, 2019
apatinib
apatinib 500mg/qd, 28d/cycle
Nanjing 81 Hospital, Nanjing
the first affiliated hospital with Nanjing Medical University, Nanjing
the second hospital of Changzhou city, Changzhou
Jiangnan University affiliated hospital, Wuxi
Jiangsu HengRui Medicine Co., Ltd.
INDUSTRY
Beijing gene plus technology co., LTD
UNKNOWN
The First Affiliated Hospital with Nanjing Medical University
OTHER